Mancheng Gong

669 total citations
21 papers, 520 citations indexed

About

Mancheng Gong is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Mancheng Gong has authored 21 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Mancheng Gong's work include Ferroptosis and cancer prognosis (6 papers), Renal cell carcinoma treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Mancheng Gong is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), Renal cell carcinoma treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Mancheng Gong collaborates with scholars based in China and Germany. Mancheng Gong's co-authors include Ruihua An, Wenjing Dong, Yangyang Xu, Wenjun Ni, Rui Ren, Erlin Song, Guiying Guo, Wenjing Dong, Shaopeng Qiu and Guiying Huang and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Journal of Cellular Biochemistry.

In The Last Decade

Mancheng Gong

21 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mancheng Gong China 12 220 177 109 93 81 21 520
Hayahito Nomi Japan 14 246 1.1× 172 1.0× 109 1.0× 56 0.6× 126 1.6× 52 627
Tadahiro Isoyama Japan 11 172 0.8× 88 0.5× 49 0.4× 33 0.4× 100 1.2× 32 449
Ju Guo China 13 286 1.3× 161 0.9× 26 0.2× 34 0.4× 74 0.9× 41 458
Choichiro Ozu Japan 12 158 0.7× 146 0.8× 63 0.6× 34 0.4× 269 3.3× 22 579
John Papadopoulos United States 10 112 0.5× 126 0.7× 31 0.3× 24 0.3× 103 1.3× 20 373
Eriko Toyoda Japan 12 238 1.1× 28 0.2× 75 0.7× 129 1.4× 130 1.6× 29 543
Shaoxing Zhu China 11 159 0.7× 125 0.7× 40 0.4× 26 0.3× 114 1.4× 37 457
Kosuke Ueda Japan 13 167 0.8× 152 0.9× 19 0.2× 27 0.3× 228 2.8× 59 556
K.-H. Bichler Germany 8 127 0.6× 101 0.6× 39 0.4× 32 0.3× 55 0.7× 38 318

Countries citing papers authored by Mancheng Gong

Since Specialization
Citations

This map shows the geographic impact of Mancheng Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mancheng Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mancheng Gong more than expected).

Fields of papers citing papers by Mancheng Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mancheng Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mancheng Gong. The network helps show where Mancheng Gong may publish in the future.

Co-authorship network of co-authors of Mancheng Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Mancheng Gong. A scholar is included among the top collaborators of Mancheng Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mancheng Gong. Mancheng Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Dongsheng, Yueming Li, Jie Kong, et al.. (2024). Prediction of Ki-67 expression in bladder cancer based on CT radiomics nomogram. Frontiers in Oncology. 14. 1276526–1276526. 6 indexed citations
3.
Gong, Mancheng, Dongsheng Zhou, Jinquan Luo, et al.. (2023). Upregulation of BMP1 through ncRNAs correlates with adverse outcomes and immune infiltration in clear cell renal cell carcinoma. European journal of medical research. 28(1). 440–440. 3 indexed citations
4.
Gong, Mancheng, Dongsheng Zhou, Jie Kong, et al.. (2023). A CT-based radiomics nomogram for differentiation of benign and malignant small renal masses (≤4 cm). Translational Oncology. 29. 101627–101627. 6 indexed citations
5.
Gong, Mancheng, et al.. (2022). OIP5 Is a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates. Frontiers in Immunology. 13. 805552–805552. 7 indexed citations
6.
Chen, Weitian, et al.. (2022). CT-based deep learning radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer. Frontiers in Oncology. 12. 1019749–1019749. 14 indexed citations
7.
Dong, Wenjing, et al.. (2022). Long non-coding RNA (FALEC) promotes malignant behaviors of gastric cancer cells by regulating miR-203b/PIM3 axis. Annals of Translational Medicine. 10(10). 579–579. 4 indexed citations
8.
Gong, Mancheng, et al.. (2021). Enhanced Expression of CNTD2/CCNP Predicts Poor Prognosis in Bladder Cancer Based on the GSE13507. Frontiers in Genetics. 12. 579900–579900. 1 indexed citations
9.
Ni, Wenjun, Meng Li, Jiayi Cui, et al.. (2017). 808 nm light triggered black TiO2 nanoparticles for killing of bladder cancer cells. Materials Science and Engineering C. 81. 252–260. 48 indexed citations
10.
Ni, Wenjun, Erlin Song, Mancheng Gong, et al.. (2017). Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma. OncoTargets and Therapy. Volume 10. 3039–3047. 10 indexed citations
11.
Dong, Wenjing, et al.. (2016). Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies. PLoS ONE. 11(3). e0152448–e0152448. 46 indexed citations
12.
13.
Gong, Mancheng, et al.. (2015). MTHFR 677C>T Polymorphism Increases the Male Infertility Risk: A Meta-Analysis Involving 26 Studies. PLoS ONE. 10(3). e0121147–e0121147. 51 indexed citations
15.
Gong, Mancheng, et al.. (2015). Tamsulosin combined with solifenacin versus tamsulosin monotherapy for male lower urinary tract symptoms: a meta-analysis. Current Medical Research and Opinion. 31(9). 1781–1792. 19 indexed citations
16.
Gong, Mancheng, Yangyang Xu, Wenjing Dong, et al.. (2013). Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma. Acta Histochemica. 115(8). 810–815. 23 indexed citations
17.
Xu, Yangyang, et al.. (2013). Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment. Cancer Biology & Therapy. 14(10). 897–906. 20 indexed citations
18.
Guo, Guiying, Yangyang Xu, Mancheng Gong, Yan Cao, & Ruihua An. (2013). USP28 is a potential prognostic marker for bladder cancer. Tumor Biology. 35(5). 4017–4022. 29 indexed citations
19.
Gong, Mancheng, Wenjing Dong, & Ruihua An. (2012). Glutathione S-transferase T1 Polymorphism Contributes to Bladder Cancer Risk: A Meta-Analysis Involving 50 Studies. DNA and Cell Biology. 31(7). 1187–1197. 30 indexed citations
20.
Gong, Mancheng, et al.. (2012). Genetic Polymorphisms of GSTM1, GSTT1, and GSTP1 with Prostate Cancer Risk: A Meta-Analysis of 57 Studies. PLoS ONE. 7(11). e50587–e50587. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026